Evaluation of Cannabidiol effect in treatment of patients with Obsessive-Compulsive Disorder
Phase 3
Recruiting
- Conditions
- Obsessive compulsive disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20210310050660N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Being healthy
Obssesive compulsive disorder (OCD) diagnosis through DSM-5 criteria ( DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 5TH EDITION)
Achieving at least score 16 according to YALE BROWN OBSSESIVE COMPLUSIVE SCORE ( YBOS)
Being only on SSRIs through recent 4 weeks
Do not have history of using cannabis or other ilicit drugs
Exclusion Criteria
Unwilling to participate in this study
Having history of other psychiatric disorder including psychotic, cognitive and substance use disorder
Being medically ill that cause more side effects than usual
Pregnancy, expecting to being pregnant and lactation
Achieving score more than 17 through completing Beck Depression scale before starting study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intensity of obsessive-compulsive disorder. Timepoint: Before entering into study, in week 4 and 8. Method of measurement: Yale–Brown Obsessive Compulsive Scale.
- Secondary Outcome Measures
Name Time Method